V2005
[deamino-Pen1, Val4, D-Arg8]-Vasopressin
≥97% (HPLC)
Sign In to View Organizational & Contract Pricing.
About This Item
Empirical Formula (Hill Notation):
C48H69N13O11S2
CAS Number:
Molecular Weight:
1068.27
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
assay
≥97% (HPLC)
storage temp.
−20°C
SMILES string
CC(C)C1NC(=O)C(Cc2ccccc2)NC(=O)C(Cc3ccc(O)cc3)NC(=O)CC(C)(C)SSCC(NC(=O)C(CC(N)=O)NC1=O)C(=O)N4CCCC4C(=O)NC(CCCNC(N)=N)C(=O)NCC(N)=O
Biochem/physiol Actions
Agonist at the V2 vasopressin receptor (antidiuretic) and antagonist at the V1 receptor (vasopressor).
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
P F Mento et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 175(1), 58-63 (1984-01-01)
The roles of arginine vasopressin (AVP), the sympathetic nervous system, and the renin-angiotensin system in maintaining elevated blood pressure in established DOC-salt hypertension in rats were studied by injection of specific antagonists of these systems. The specific AVP antagonist dPVDAVP
S Lluch et al.
The Journal of pharmacology and experimental therapeutics, 228(3), 749-755 (1984-03-01)
The effects of vasopressin on the cerebral circulation were studied in conscious goats and in isolated human and goat cerebral arteries. Infusion of 1 to 12 mU of vasopressin into the internal maxillary artery of unanesthetized goats caused dose-dependent reductions
D L Chen et al.
Journal of reproduction and fertility, 102(2), 337-343 (1994-11-01)
This paper describes further pharmacological characterization of the decidual prostaglandin-releasing oxytocin receptors and the myometrial uterotonic oxytocin receptors in the uterus of the pregnant rat. The effects of oxytocin, arginine-vasopressin and their related agonists and antagonists on the release of
D C Leitman et al.
Endocrinology, 122(4), 1478-1485 (1988-04-01)
The effect of atrial natriuretic peptide (ANP), arginine vasopressin (AVP), and oxytocin (OT) on cAMP and cGMP accumulation was investigated in LLC-PK1 kidney epithelial cells. The addition of ANP, AVP, and OT to intact cells produced a time- and concentration-dependent
Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
T Nakata et al.
American journal of hypertension, 2(8), 625-630 (1989-08-01)
To determine whether paraventricular nucleus (PVN) can play a role in the hypertension in DOCA/salt-treated rats, DOCA/salt hypertension was produced in PVN lesions and sham-operated rats. In lesioned rats, the development of hypertension was significantly attenuated (day 7: 132 +/-
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service